Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation.

The EMBO journal | Jun 4, 2008

http://www.ncbi.nlm.nih.gov/pubmed/18451802

In response to stimuli that activate p53, cells can undergo either apoptosis or cell cycle arrest, depending on the precise pattern of p53 target genes that is activated. We show here that Zbtb4, a transcriptional repressor protein, associates with the Sin3/histone deacetylase co-repressor and represses expression of P21CIP1 as part of a heterodimeric complex with Miz1. In vivo, expression of ZBTB4 is downregulated in advanced stages of multiple human tumours. In cell culture, depletion of ZBTB4 promotes cell cycle arrest in response to activation of p53 and suppresses apoptosis through regulation of P21CIP1, thereby promoting long-term cell survival. Our data suggest that Zbtb4 is a critical determinant of the cellular response to p53 activation and reinforce the notion that p21Cip1 can provide an essential survival signal in cells with activated p53.

Pubmed ID: 18451802 RIS Download

Mesh terms: Apoptosis | Cell Cycle | Child | Cyclin-Dependent Kinase Inhibitor p21 | DNA-Binding Proteins | Down-Regulation | Gene Expression Regulation | Humans | Kruppel-Like Transcription Factors | Neoplasms | Promoter Regions, Genetic | Repressor Proteins | Transcription Factors | Transcription, Genetic | Tumor Cells, Cultured | Tumor Suppressor Protein p53

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA57138
  • Agency: NCI NIH HHS, Id: T32 CA 09229
  • Agency: NCI NIH HHS, Id: T32 CA09657

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.